Furrer et al. found that pre-diagnosis alcohol consumption improved disease-free survival in HER2-positive breast cancer patients, while Lemieux et al. reported that high alcohol intake during trastuzumab treatment was linked to increased cardiac toxicity. The gene discussed is ERBB2; the disease is breast carcinoma.